Forecasting

StratInova excels in new product forecasting. Our customized forecasts are completed in-house and are completely transparent. We do not outsource our forecasting work and we do not lock any part of the forecast. This allows clients the ease of updating the forecast model as new assumptions become available.

Extensive experience using sophisticated modeling techniques is a requirement for companies developing new products that are targeting unique patient segments, which have not historically been separated from broader indications. StratInova’s lead forecaster has over 11 years of experience building accurate patient flows and unique calculations to forecast complicated patient segments. Our forecasting work often includes scenario analysis (if clinical trial strategy is not entirely decided), sensitivity analysis (considering range in assumptions), and decision tree analysis (financial modeling accounting for different development outcomes).

Our forecasting team often corresponds with the client’s financial group to review variances and factors impacting future projections.

StratInova also maintains and updates major brand forecasts on a quarterly basis for some clients. This provides a cost-effective solution for companies with limited forecasting resources.

Our forecast models typically include the G7 markets, but we have forecasted up to 40 countries in a single forecast model.